Lista substancji oferowanych przez Łukasiewicz – Instytut Chemii Przemysłowej im. Profesora Ignacego Mościckiego:
Substancja | Numer CAS | Pole działania | Dostępne certyfikaty | |
Alfacalcidol API | 41294-56-8 | regulator metabolizmu wapnia, analog witaminy D | CEP, GMP, ASMF | |
Anastrozole API | 120511-73-1 | przeciwnowotworowy, niesteroidowy inhibitor aromatazy | GMP, ASMF | |
Brinzolamide API | 138890-62-7 | jaskra, inhibitor anhydrazy węglanowej | ASMF | |
Calcifediol API | 19356-17-3 | regulator metabolizmu wapnia, analog witaminy D | GMP, ASMF | |
Calcitriol API | 32222-06-3 | regulator metabolizmu wapnia, analog witaminy D | CEP, GMP, ASMF | |
Carvedilol API | 72956-09-3 | leki sercowo-naczyniowe, beta-adrenolityki | GMP, ASMF | |
Cilostazol API | 73963-72-1 | inhibitor fosfodiesterazy PDE3 – hamuje agregację płytek krwi oraz rozszerza naczynia krwionośne | ASMF | |
(+)-Clopidogrel Hydrogen sulfate, polymorphic form I API | 120202-66-6 | inhibitor agregacji płytek krwi, pochodna tienopirydyny | GMP, ASMF | |
Genistein synthetic API | 446-72-0 | Fitoestrogen z grupy izoflawonów | ASMF | |
Imatinib mesylate polymorphic form α API |
220127-57-1 | inhibitorów kinaz białkowych (hamuje receptory kinazy tyrozynowej) | GMP, ASMF | |
Latanoprost API | 130209-82-4 | jaskra z otwartym kątem przesączania, nadciśnienie śródgałkowe, pochodna prostaglandyny | GMP, ASMF | |
Nitrendipine API | 39562-70-4 | antagonista wapnia (bloker kanału wapniowego) | GMP, ASMF | |
Olanzapine polymorphic
form I API |
132539-06-1 | lek antypsychotyczny, antagonista serotoniny/dopaminy | GMP, ASMF | |
Paricalcitol API | 131918-61-1 | inhibitor wydzielania hormonu przytarczyc, analog witaminy D | GMP, ASMF | |
Pramipexole dihydrochloride, monohydrate API | 104632-26-0 | wybiórczy agonista receptorów dopaminowych, choroba Parkinsona | ASMF | |
Tacalcitol API | 57333-96-7 | Leki przeciwłuszczycowe do stosowania miejscowego, analog witaminy D | GMP, ASMF | |
Cladribine API | 4291-63-8 | Antagonista purynowy, syntetyczna pochodna deoksyadenozyny (dA) | GMP, ASMF | |
Biodribin | – | lek przeciwnowotworowy stosowany w chemioterapii nowotworów (białaczka włochatokomórkowa, przewlekła białaczka limfatyczna, chłoniaki nieziarniczne) | GMP |
ASMF – Active Substance Master File
GMP – Certyfikat GMP wydany przez Główny Inspektorat Farmaceutyczny
CEP – Certificate of Suitability issued by EDQM (European Directorate for the Quality in Medicines and Healthcare)
Lista wzorców analitycznych oferowanych przez Łukasiewicz – Instytut Chemii Przemysłowej im. Profesora Ignacego Mościckiego:
Alfacalcidol:
Alfacalcidol Reference Standard (CAS 41294-56-8);
Alfacalcidol impurity A (trans-Alfacalcidol) Working Standard (CAS 65445-14-9);
Alfacalcidol impurity B (1β-Calcidol) Working Standard (CAS 63181-13-5);
Amitraz:
Amitraz Reference Standard (CAS 33089-61-1);
Amitraz impurity A Working Standard (CAS 95-68-1);
Amitraz impurity B Working Standard (60397-77-5);
Amitraz impurity C Working Standard (CAS 33089-74-6);
Amitraz impurity D Working Standard (16596-04-6);
Anastrozole:
Anastrozole Reference Standard (CAS 120511-73-1);
Anastrozole impurity A Working Standard (120511-72-0);
Bimatoprost:
Bimatoprost Reference Standard (CAS 155206-00-1);
15-epi-Bimatoprost Working Standard (CAS 1163135-92-9);
Bimatoprost impurity 2,2-Bis(hydroxymethyl)propyl (Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-enyl]-cyclopentyl}hept-5-enoate Working Standard;
Bimatoprost acid Working Standard (CAS 38344-08-1);
Bimatoprost impurity (S)-4-phenyl-2-tert-butyldimethylsilyloxy-butan-1-ol Working Standard;
Calcifediol:
Calcifediol Reference Standard (CAS 63283-36-3);
Calcifediol impurity D (trans-Calcifediol) Working Standard (CAS 36149-00-5);
Calcipotriol:
Calcipotriol anhydrous Reference Standard (CAS 112965-21-6);
Calcipotriol impurity C (trans-Calcipotriol) Working Standard (CAS 113082-99-8);
Calcipotriol impurity D (24-epi-Calcipotriol) Working Standard (CAS 112827-99-3);
Calcitriol:
Calcitriol Reference Standard (CAS 32222-06-3);
Calcitriol impurity A (trans-Calcitriol) Working Standard (CAS 73837-24-8);
Calcitriol impurity B (1β-Calcitriol) Working Standard (CAS 66791-71-7);
Capecitabine:
Capecitabine Reference Standard (CAS 154361-50-9);
Carvedilol:
Carvedilol Reference Standard (CAS 72956-09-3);
Carvedilol impurity Cd-2 Working Standard (CAS 1836-62-0);
Carvedilol impurity Cd-5 Working Standard (CAS 52602-39-8);
Carvedilol impurity Cd-6 Working Standard (CAS 51997-51-4);
Carvedilol impurity A Working Standard (CAS 1198090-73-1);
Carvedilol impurity B Working Standard (CAS 918903-20-5);
Carvedilol impurity C Working Standard (CAS 72955-94-3);
Duloxetine hydrochloride:
Duloxetine hydrochloride Reference Standard (CAS 136434-34-9);
Eplerenone:
Eplerenone Reference Standard (CAS 107724-20-9);
Imatinib:
Imatinib Mesylate Form α Reference Standard (CAS 220127-57-1);
Imatinib impurity IM-5 Working Standard (CAS 152460-10-1);
Imatinib impurity IM-6 Working Standard (CAS 404844-11-7);
Imatinib impurity Z-1 Working Standard (CAS 407844-03-7);
Imatinib impurity Z-2 Working Standard;
Imatinib impurity Z-3 Working Standard;
Imatinib impurity Z-4 Working Standard (CAS 571186-91-9);
Imatinib impurity GV-2 Working Standard (CAS 152460-08-7);
Imatinib impurity GV-5 Working Standard (CAS 55314-16-4);
Imatinib impurity GV-6 Working Standard (CAS 152460-09-8);
Imatinib impurity Isopropyl Methanosulfonate Working Standard (CAS 926-06-7);
Imatinib impurity Ethyl Methanosulfonate Working Standard (CAS 62-50-0);
Imatinib impurity 4-(Chloromethyl)benzoic acid Working Standard (CAS 1642-81-5);
Imatinib impurity Methyl 4-(chloromethyl)benzoate Working Standard
(CAS 34040-64-7);
Imatinib impurity 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride Working Standard;
Lacidipine:
Lacidipine impurity B Working Standard (CAS 130996-24-6);
Lacidipine impurity C Working Standard (CAS 103890-79-5);
Latanoprost:
Latanoprost Reference Standard (CAS 130209-82-4);
15-epi-Latanoprost Working Standard (CAS 145773-22-4);
5,6-trans-Latanoprost Working Standard (CAS 913258-34-1);
Latanoprost acid Working Standard (CAS 41639-83-2);
Linezolid:
Linezolid Reference Standard (CAS 165800-03-3);
Montelukast:
Montelukast Reference Standard (CAS 1187586-63-5);
Montelukast impurity A (epi-Montelukast acid) Working Standard (CAS 220927-27-5);
Montelukast impurity B (Montelukast Methylstyrene) Working Standard
(CAS 918972-54-0);
Montelukast impurity (Montelukast disulfide) Working Standard (CAS 162515-67-5);
Olanzapine:
Olanzapine Form I Reference Standard (CAS 132539-06-1);
Olanzapine impurity S Working Standard;
Olanzapine impurity L Working Standard (CAS 221176-49-4);
Olanzapine impurity G Working Standard;
Repaglinide:
Repaglinide Reference Standard (CAS 135062-02-1);
Tacalcitol:
Tacalcitol monohydrate Reference Standard (CAS 93129-94-3);
Tacalcitol impurity A (trans-Tacalcitol) Working Standard (CAS 1294517-97-7);
Tacalcitol impurity B ((24S)-Tacalcitol) Working Standard (CAS 57333-95-6);
Tacalcitol impurity C (1β-Tacalcitol) Working Standard (CAS 169218-36-4);
Travoprost:
Travoprost Reference Standard (CAS 157283-68-6);
15-epi-Travoprost Working Standard;
5,6-trans-Travoprost Working Standard;
Travoprtost acid Working Standard (CAS 54276-17-4);
Travoprtost impurity 2,2-Bis(hydroxymethyl)propyl (Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(R,E)-3-hydroxy-4-(3-trifluoromethylphenoxy)but-1-enyl]cyclopentyl}hept-5-enoate Working Standard;
Travoprtost impurity (R)-(–)-2-(tert-butyldimethylsilyloxy)-3-(3-trifluoromethylphenoxy)propan-1-ol WS;
Zolmitriptan:
Zolmitriptan Reference Standard (CAS 139264-17-8);
For more details about analytical standards produced by Łukasiewicz Research Network – Industrial Chemistry Institute contact anna.nikonowicz@ichp.lukasiewicz.gov.pl
Do pobrania: Lista wzorców analitycznych